BDBM268306 4-(2,3-difluorophenyl)-2- (morpholin-4-yl)-8-(1H-pyrazol-5- yl)-1,7-naphthyridine::US10772893, Example 341::US11529356, Example 341::US9549932, 341

SMILES Fc1cccc(c1F)-c1cc(nc2c(nccc12)-c1ccn[nH]1)N1CCOCC1

InChI Key InChIKey=CXEFIDJGTRZTQO-UHFFFAOYSA-N

Data  3 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 3 hits for monomerid = 268306   

TargetSerine/threonine-protein kinase ATR(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM268306(US9549932, 341 | 4-(2,3-difluorophenyl)-2- (morpho...)
Affinity DataIC50: 26.4nMpH: 7.0Assay Description:To determine of binding activity of the test compounds, full-length human ATR protein was expressed and purified together with ATRIP as described abo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/29/2018
Entry Details
US Patent

TargetATR-interacting protein/Serine/threonine-protein kinase ATR(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM268306(US9549932, 341 | 4-(2,3-difluorophenyl)-2- (morpho...)
Affinity DataIC50: 26.4nMAssay Description:To determine of binding activity of the test compounds, full-length human ATR protein was expressed and purified together with ATRIP as described abo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/25/2021
Entry Details
US Patent

TargetATR-interacting protein/Serine/threonine-protein kinase ATR(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM268306(US9549932, 341 | 4-(2,3-difluorophenyl)-2- (morpho...)
Affinity DataIC50: 26.4nMAssay Description:For the assay 50 nl of a 100-fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/16/2023
Entry Details
US Patent